Cargando…

Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019

Detalles Bibliográficos
Autores principales:	Haston, Julia C., Hwang, Jimee, Tan, Kathrine R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2019
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871897/ https://www.ncbi.nlm.nih.gov/pubmed/31751320 http://dx.doi.org/10.15585/mmwr.mm6846a4

Ejemplares similares

Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping
por: Beck, Hans-Peter, et al.
Publicado: (2016)

Tafenoquine: a toxicity overview
por: Chu, Cindy S., et al.
Publicado: (2021)

Tafenoquine succinate for malaria prevention
Publicado: (2019)

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
por: Rajapakse, Senaka, et al.
Publicado: (2015)

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
por: Lacerda, M.V.G., et al.
Publicado: (2019)

Dual-Luciferase-Based Fast and Sensitive Detection of Malaria Hypnozoites for the Discovery of Antirelapse Compounds
por: Voorberg-van der Wel, Annemarie M., et al.
Publicado: (2020)

Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax
por: Rajgor, D. D., et al.
Publicado: (2014)

Tafenoquine for travelers' malaria: evidence, rationale and recommendations
por: Baird, J Kevin
Publicado: (2018)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
por: Ebstie, Yehenew A, et al.
Publicado: (2016)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
por: Commons, Robert J, et al.
Publicado: (2020)

Updated CDC Recommendations for Using Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in Pregnant Women in the United States
por: Ballard, Sarah-Blythe, et al.
Publicado: (2018)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
por: St Jean, Pamela L., et al.
Publicado: (2020)

Tafenoquine for Plasmodium vivax malaria: Concerns regarding efficacy & safety
por: Sharma, Jatin, et al.
Publicado: (2021)

Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency
por: Taylor, Walter R J, et al.
Publicado: (2019)

Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022
por: O’Shea, Jesse, et al.
Publicado: (2022)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
por: Baird, J Kevin
Publicado: (2021)

Characteristics Associated with Adults Remembering to Wash Hands in Multiple Situations Before and During the COVID-19 Pandemic — United States, October 2019 and June 2020
por: Haston, Julia C., et al.
Publicado: (2020)

Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020
por: Patel, Anita, et al.
Publicado: (2020)

Corrigendum to: Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency
por: Taylor, Walter R J, et al.
Publicado: (2020)

Tuberculosis — United States, 2019
por: Schwartz, Noah G., et al.
Publicado: (2020)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018)

Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
por: Suh, Jiyeon, et al.
Publicado: (2022)

Malaria Surveillance — United States, 2015
por: Mace, Kimberly E., et al.
Publicado: (2018)

Malaria Surveillance — United States, 2017
por: Mace, Kimberly E., et al.
Publicado: (2021)

Malaria Surveillance — United States, 2018
por: Mace, Kimberly E., et al.
Publicado: (2022)

Severe Morbidity and Mortality Risk From Malaria in the United States, 1985–2011
por: Hwang, Jimee, et al.
Publicado: (2014)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
por: Ahmad, Sundus Shafat, et al.
Publicado: (2021)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
por: Markus, Miles B
Publicado: (2021)

Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
por: Hounkpatin, Aurore B, et al.
Publicado: (2019)

Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria
por: Mayence, Annie, et al.
Publicado: (2019)

Economic Cost of Injury — United States, 2019
por: Peterson, Cora, et al.
Publicado: (2021)

Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019
por: Jatlaoui, Tara C., et al.
Publicado: (2019)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
por: Duparc, Stephan, et al.
Publicado: (2020)

State-Level Economic Costs of Fatal Injuries — United States, 2019
por: Peterson, Cora, et al.
Publicado: (2021)

Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial
por: Thakkar, Nilay, et al.
Publicado: (2018)

An Efficient and Sustainable Synthesis of the Antimalarial Drug Tafenoquine
por: Kavthe, Rahul D., et al.
Publicado: (2022)

Changes in Suicide Rates — United States, 2018–2019
por: Stone, Deborah M., et al.
Publicado: (2021)

Prevalence of Diagnosed Arthritis — United States, 2019–2021
por: Fallon, Elizabeth A., et al.
Publicado: (2023)

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
por: Birrell, Geoffrey W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jjs56an755qiehfp5t4sqf98f4